<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Act of 1934
(Amendment No. _____________)*
FLEMINGTON PHARMACEUTICAL CORPORATION
- ------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, $ .01 par value
- ------------------------------------------------------------------------------
(Title of Class of Securities)
339280 10 9
---------------------------
(CUSIP Number)
<PAGE>
- ---------------------------- -----------------------
CUSIP NO. 339280 10 9 13G Page 2 of 5 Pages
-----------
- ---------------------------- -----------------------
- ------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Harry A. Dugger III
###-##-####
- ------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a)
(b)
- ------------------------------------------------------------------------------
3 SEC USE ONLY
- ------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
U.S.A.
- ------------------------------------------------------------------------------
5 SOLE VOTING POWER
1,559,003
----------------------------------------------------
NUMBER OF SHARES EACH 6 SHARED VOTING POWER
BENEFICIALLY
0
----------------------------------------------------
OWNED BY 7 SOLE DISPOSITIVE POWER
REPORTING PERSON WITH
1,559,003
----------------------------------------------------
8 SHARED DISPOSITIVE POWER
0
- ------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,559,003
- ------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
(1)
- ------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
40.2%
- ------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
- ------------------------------------------------------------------------------
(1) The aggregate amount set forth in Row 9 excludes 120,000 shares owned by
the reporting person's son, Andrew Dugger (60,000) and daughter Christina
D. Sommer (60,000) for which the reporting person disclaims beneficial
ownership for purposes of this filing.
-2-
<PAGE>
Item 1.
(a) Name of Issuer: Flemington Pharmaceutical Corporation
(b) Address of Issuer's Principal Executive Offices:
43 Emery Avenue, Flemington, New Jersey 08822
Item 2.
(a) Name of Person Filing: Harry A. Dugger III
(b) Address: 548 Sergeantsville Road,
Flemington, New Jersey 08822
(c) Citizenship: U.S.A.
(d) Title of Class of Securities: Common Stock, $.01 par value
(e) CUSIP Number: 339280 10 9
Item 3. IF THIS STATEMENT IS FILED PURSUANT TO RULE 13d-l(b), OR 13d-2(b),
CHECK WHETHER THE PERSON FILING IS A: Not Applicable.
(a) [ ] Broker or Dealer registered under Section 15 of the Act
(b) [ ] Bank as defined in section 3(a)(6) of the Act
(c) [ ] Insurance Company as defined in section 3(a)(19) of the
act
(d) [ ] Investment Company registered under section 8 of the
Investment Company Act
(e) [ ] Investment Adviser registered under section 203 of the
Investment Advisers Act of 1940
(f) [ ] Employee Benefit Plan, Pension Fund which is subject to
the provisions of the Employee Retirement Income Security Act
of 1974 or Endowment Fund; see ss. 240.13d-1(b)(1)(ii)(F)
(g) [ ] Parent Holding Company, in accordance with
ss.240.13d-l(b)(ii)(G)
(h) [ ] Group, in accordance with ss. 240.13d-1(b)(1)(ii)(H)
Item 4. OWNERSHIP
(a) Amount Benefically Owned: 1,559,003
(b) Percent of Class: 40.2%
-3-
<PAGE>
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 1,559,003
(ii) shared power to vote or to direct the vote: 0
(iii) sole power to dispose or to direct the disposition of: 1,559,003
(iv) shared power to dispose or to direct the disposition of: 0
Item 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS: Not Applicable.
If this statement is being filed to report the fact that as of the date hereof
the reporting person has ceased to be the beneficial owner of more than five
percent of the class of securities, checkthe following [ ].
Item 6. OWNERSHIP OF MORE THAT FIVE PERCENT ON BEHALF OF ANOTHER PERSON: Not
Applicable.
Item 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE
SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY: Not Applicable.
Item 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP: Not
Applicable.
Item 9. NOTICE OF DISSOLUTION OF GROUP: Not Applicable.
Item 10. CERTIFICATION:
By signing below I certify that, to the best of my knowledge and belief, the
securities referred to above were acquired in the ordinary course of business
and were not acquired for the purpose of and do not have the effect of
changing or influencing the control of the issuer of such securities and were
not acquired in connection with or as a participant in any transaction having
such purposes or effect.
-4-
<PAGE>
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct
March 9, 1998
-----------------------------
(date)
/s/ Harry A. Dugger III, Ph.D.
------------------------------
Signature
Harry A. Dugger III, Ph.D., President
-------------------------------------
Name/Title
-5-
